SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-042512
Filing Date
2024-04-02
Accepted
2024-04-02 16:15:21
Documents
1
Period of Report
2024-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2410563-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2410563-1_4seq1.xml 4 4464
  Complete submission text file 0001104659-24-042512.txt   5906
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address
Fisher Andrew (Reporting) CIK: 0002014301 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38067 | Film No.: 24814380